Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values

Journal of Hypertension

Volumn 27, Issue 12, 2009, Pages 2458-2464

  Bombelli, Michele ^a   Facchetti, Rita ^a   Carugo, Stefano ^b   Madotto, Fabiana ^c   Arenare, Francesca ^c   Quarti Trevano, Fosca ^a   Capra, Anna ^a   Giannattasio, Cristina ^a,d   Dell'Oro, Raffaella ^a   Grassi, Guido ^a,b,d   Sega, Roberto ^a   Mancia, Giuseppe ^a,b,d  

^a SAN GERARDO HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c IRCCS MULTIMEDICA   (Italy)

^d ISTITUTO AUXOLOGICO ITALIANO   (Italy)

Author keywords

Ambulatory blood pressure; Cardiovascular risk; Home blood pressure; Left ventricular hypertrophy

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HOME MONITORING; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 73249124082     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328330b845     Document Type: Article

References (33)

1. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322:1561-1566. (Pubitemid 20176696)
2. Kannel WB. Left ventricular hypertrophy as a risk factor in arterial hypertension. Eur Heart J 1992; 13:82-88.
3. Okin PM, Devereux RB, Nieminen MS,Jern S, Oikarlnen L, Viitasalo M, et al. Electrocardiographic strain pattern and prediction of cardiovascular morbidity and mortality in hypertensive patients. Hypertension 2004; 44:48-54. (Pubitemid 38823486)
4. Franklin SS, Wachtell K, Papademetriou V, Olsen MH, Devereux RB, Fyhrquist F, et al. Cardiovascular morbidity and mortality In hypertensive patients with lower versus higher risk: a LIFE substudy. Hypertension 2005; 46:492-499. (Pubitemid 41376828)
5. Okin PM, Devereux RB, Nieminen MS, Jern S. Oikarlnen L, Viitasalo M, et al. Electrocardiographic strain pattern and prediction of new-onset congestive heart failure in hypertensive patients: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study. Circulation 2006; 113:67-73. (Pubitemid 43958490)
6. Ruilope LM, Schmieder RE. Left ventricular hypertrophy and clinical outcomes In hypertensive patients. Am J Hypertens 2008; 21:500-508. (Pubitemid 351589672)
7. Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension 2005; 46:156-161. (Pubitemid 40946507)
8. Staessen JA, Thijs L, Fagard R, O'Brien ET. Clement D, de Leeuw PW, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA 1999; 282:539-546.
9. Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med 2003; 348:2407-2415. (Pubitemid 36682819)
10. Fagard RH, Van Den Broeke C, De Cort P. Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice. J Hum Hypertens 2005; 19:801-807. (Pubitemid 41486143)
11. Sega R, Facchetti R, Bombelli M, Cessna G, Corrao G, Grassi G, Mancia G. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation 2006; 111:1777-1783. (Pubitemid 40525142)
12. Mancia G, Parati G, Bilo G, Maronati A, Omboni S, Baurecht H, et al. Assessment of long-term antihypertensive treatment by clinic and ambulatory blood pressure: data from the European Lacidipine Study on Atherosclerosis. J Hypertens 2007; 25:1087-1094. (Pubitemid 46573129)
13. Mancia G, Omboni S, Parati G, Clement DL, Haley WE, Rahman SN, Hoogma RP. Twenty-four hour ambulatory blood pressure in the Hypertension Optimal Treatment (HOT) study. J Hypertens 2001 ; 19:1755-1763. (Pubitemid 32924940)
14. Mancia G, Parati G. The role of blood pressure variability in end-organ damage. J Hypertens 2003; 21 (Suppl):S17-S23. (Pubitemid 37082785)
15. Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension 2006; 47:846-853. (Pubitemid 44297554)
16. Verdecchia P, Borgioni C, Ciucci A, Gattobigio R, Schillaci G, Sacchi N, et al. Prognostic significance of blood pressure variability In essential hypertension. Stood Press Monit 1996; 1:3-11. (Pubitemid 126441344)
17. WHO-MONICA Project Principal Investigators. The World Health Organization Monica Project: a major international collaboration. J Clin Epidemiol 1998; 41:105-114.
18. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Circulation 1977; 55:613-618.
19. Sahn DY, De Maria A, Kinlo J, Weyman A, for the Committee on M-mode standardization of the American Society of Echocardiography. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiography measurements. Circulation 1978; 58:1072-1083.
20. Anderson RN, Rosenberg HM. Disease classification: measuring the effect of the Tenth Revision of the International Classification of Diseases on cause-of-death in the United States. Stat Med 2003; 15:1551-1570.
21. Groppelli A, Omboni S, Parati G, Mancia G. Evaluation of noninvasive blood pressure monitoring devices Spacelabs 90202 and 90207 versus resting and ambulatory 24 h intraarterial blood pressure. Hypertension 1992; 20:227-232.
22. Sega R, Corrao G, Bombelli M, Beltrame L, Facchetti R, Grassi G, et al. Blood pressure variability and organ damage in a general population: results from the PAMELA study (Pressioni Arteriose Monitorate E Loro Associazioni). Hypertension 2002; 39:710-714.
23. Dubois D, Dubois EF. A formula to estimate the approximative surface area if height and weight are known. Arch Intern Med 1916; 17:863-871.
24. Ganau A, Devereux RB, Roman MJ, De Simone G, Pickering T, Saba P, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992; 19:1560-11558
25. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Battistelli M, Bartoccini C, et al. Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass. J Am Coll Cardiol 1995; 25:871-878.
26. Paulus WJ, Tschope C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007; 28:2539-2550. (Pubitemid 47614269)
27. Sadler DB, Aurigemma GP, Williams DW, Reda DJ, Materson BJ, Gottdiener JS. Systolic function in hypertensive men with concentric remodeling. Hypertension 1997; 30:777-781.
28. de Simone G, Devereux RB, Celentano A, Roman MJ. Left ventricular chamber and wall mechanics in the presence of concentric geometry. J Hypertens 1999; 17:1001-1006. (Pubitemid 29322189)
29. Devereux RB, de Simone G, Pickering TG, Schwartz JE, Roman MJ. Relation of left ventricular midwall function to cardiovascular risk factors and arterial structure and function. Hypertension 1998; 31:929-936.
30. Kozáková M, Palombo C, Pratali L, Pittella G, Galetta F, L'Abbate A. Mechanisms of coronary flow reserve impairment in human hypertension. An integrated approach by transthoracic and transesophageal echocardiography. Hypertension 1997; 29:551-559. (Pubitemid 27074717)
31. Messerli FH, Soria F. Ventricular dysrhythmias, left ventricular hypertrophy, and sudden death. Cardiovasc Drugs Ther 1994; 8:567-1563
32. Vanuzzo D, Pilotto L, Mirolo R, Pirelli S. Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation. G Ital Cardiol 2008; 9:6S-17S.
33. Ishikawa J, Ishikawa S, Kabutoya T, Gotoh T, Kayaba K, Schwartz JE, et al. Cornell product left ventricular hypertrophy In electrocardiogram and the risk of stroke in a general population. Hypertension 2009; 53:28-34.